Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - podophyllotoxin -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - podophyllotoxin -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - podophyllotoxin -

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - podophyllotoxin 0.15%{relative} - topical cream - 0.15% w/w - active: podophyllotoxin 0.15%{relative} excipient: butylated hydroxyanisole cetyl alcohol emulsifying wax isopropyl myristate liquid paraffin medium-chain triglycerides methyl hydroxybenzoate phosphoric acid propyl hydroxybenzoate purified water sorbic acid stearyl alcohol - for the topical treatment of external condylomata acuminata (anogenital warts).

Canada - English - Health Canada

stiefel laboratories (ireland) limited - podophyllotoxin - liquid - 5mg - podophyllotoxin 5mg - misc. skin and mucous membrane agents

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmaf -

New Zealand - English - Medsafe (Medicines Safety Authority)

universal specialities ltd trading as usl medical - podophyllotoxin 0.5%{relative} (includes overage to 0.569%) - topical solution - 5 mg/ml - active: podophyllotoxin 0.5%{relative} (includes overage to 0.569%) excipient: ethanol patent blue v phosphoric acid purified water

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - podophyllotoxin - cream - 0.15% w/w